They called for stability and predictability at the agency at Axios' Future of Health summit.

Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Leaders want the next FDA commissioner to be someone who can rebuild trust, focus on food policy, and drive drug-approval reforms.

Marty Makary is out, and experts are calling for a return to order